ORGANOGENESIS HOLDINGS INC.
ORGO · NASDAQ
Organogenesis Holdings Inc. is a leading regenerative medicine company offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Organogenesis's comprehensive portfolio is designed to treat a variety of patients with repair and regenerative needs.
Market Data
Price
$2.71
-0.05 (-1.81%)
Market Cap$355M
P/E Ratio9.59
EPS$—
52W High$7.08
52W Low$2.61
Beta1.36
Data from Finnhub · Updated Mar 11, 2026